2 FDA rules widen dying patients' access to unapproved drugs

08/12/2009 | Wall Street Journal, The · Reuters

The FDA finalized two rules to make certain unapproved medicines more accessible to critically ill patients who failed to respond to other treatments. The regulations guide patients in getting drugs outside clinical trials and give smaller firms a chance to participate in expanded-access programs by allowing companies and researchers to charge patients for the treatments.

View Full Article in:

Wall Street Journal, The · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN